21159 ⎘
Medicinal preparations containing antigens or antibodies comprising antibodies
METHOD OF TREATING AN AUTOIMMUNE DISEASE BY ADMINISTERING AN ANTI-HUMAN BAFF ANTIBODY
#1802Fusion Protein Construct
#1803METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) WITH AN ANTI-PCSK9 ANTIBODY
#1804Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
#1805ANTI-HER2/TROP2 ANTIBODIES AND USES THEREOF
#1806STEAP2 DIRECTED T-CELL ENGAGERS AND COMPOSITIONS THEREOF
#1807CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION THERAPY
#1808CD27 AGONISTS
#1809ANTI-OX40 ANTAGONISTIC ANTIBODIES FOR THE TREATMENT OF AUTOIMMUNE DISEASES
#1810DOSING AND TREATMENT OF IMMUNE-MEDIATED DISEASES AND BIOMARKERS ASSOCIATED WITH IMMUNE-MEDIATED DISEASES
#1811COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE
#1812CHIMERIC ANTIGEN RECEPTORS TARGETING FC RECEPTOR-LIKE 5 AND USES THEREOF
#1813DUAL SPECIFICITY ANTIBODIES TO HUMAN PD-L1 AND PD-L2 AND METHODS OF USE THEREFOR
#1814ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS
#1815TIGIT ANTIBODIES AND USES THEREOF
#1816HUMANIZED NON-OPIOID COMPOSITION AND THERAPIES FOR PAIN MANAGEMENT
#1817IL-6 ANTIBODIES
#1818COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC LUNG DISEASES
#1819ANTIBODIES FOR TREATING ALPHA-SYNUCLEINOPATHIES
#1820ERYTHROCYTE-BINDING THERAPEUTICS
#1821MULTI-SPECIFIC ANTIGEN BINDING MOLECULES TARGETING HIV AND METHODS OF USE
#1822METHODS FOR DETECTING OR TREATING INFLUENZA INFECTIONS
#1823HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF
#1824INTERLEUKIN-2 AGENTS AND USES THEREOF
#1825METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS
#1826Treatment of Proliferative Disorders Using Antibodies to PSMA
#1827PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER
#1828BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS
#1829ANTI-MUSK ANTIBODIES FOR USE IN TREATING NEUROMUSCULAR DISORDERS
#1830ANTI-CD97 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
#1831ANTI-CD38 BINDING MOLECULES AND USES THEREOF
#1832Anti-Abcb1 Antibodies
#1833ANTIBODY AGAINST OX40 AND MEDICAL USE THEREOF
#1834FAP/CD40 BINDING MOLECULE AND MEDICINAL USE THEREOF
#1835ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR
#1836EPHA2 ANTIBODIES
#1837ANTIBODIES AGAINST G-CSFR AND USES THEREOF
#1838Methods for the treatment of thyroid eye disease
#1839BISPECIFIC ANTI-VEGF AND ANTI-TRKB BINDING MOLECULES FOR THE TREATMENT OF EYE DISEASES
#1840WNT-SURROGATE AGENTS AND METHODS FOR LACRIMAL GLAND REGENERATION
#1841ASGR INHIBITORS
#1842MULTISPECIFIC ANTIBODIES AND USE THEREOF
#1843METHODS FOR TREATING BULLOUS PEMPHIGOID USING FCRN ANTAGONISTS
#1844ANTI-B7-H3 MONOCLONAL ANTIBODY AND USE THEREOF IN CELL THERAPY
#1845USE OF ANTI-PD-L1/CD47 BISPECIFIC ANTIBODY IN TREATMENT OF DISEASES
#1846Anti-CD112R Compositions and Methods
#1847LAG-3 COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#1848Anti-CD28 Humanized Antibodies Formulated for Administration to Humans
#1849MULTI-SPECIFIC T CELL ENGAGERS COMPRISING LRRC15 ANTIGEN-BINDING DOMAIN
#1850DEPLETION OF NK CELLS FOR THE TREATMENT OF ADVERSE POST-ISCHEMIC CARDIAC REMODELING
#1851Arthritis Treatment
#1852MONOVALENT INTERLEUKIN 12 (IL-12) HETERODIMERIC FC PROTEINS
#1853METHODS OF TREATING CHRONIC GRAFT-VERSUS-HOST DISEASE USING AN ANTI-COLONY STIMULATING FACTOR 1 RECEPTOR ANTIBODY
#1854Antibody Variants
#1855NEUTRALIZATION OF ACYL-COA BINDING PROTEIN CONFERS AUTOPHAGY-DEPENDENT ORGAN PROTECTION
#1856ANTI-A-BETA PROTEIN ANTIBODIES, METHODS AND USES THEREOF
#1857ANTIBODIES TO AMYLOID BETA
#1858ANTIBODIES HAVING PAN-ANTIVIRAL ACTIVITY AND METHODS THEREOF
#1859FUSION PROTEINS COMPOSED OF AN ANTIBODY AND A MUTEIN
#1860PHARMACEUTICAL COMPOSITION FOR TREATING TUMORS AND USE
#1861FERROCHELATASE INHIBITORS AND METHODS OF USE
#1862COMBINATORY THERAPY FOR CANCER USING BIPHENYL COMPOUND AND IMMUNE CHECKPOINT MOLECULE REGULATOR
#1863FC POLYPEPTIDE HAVING ALTERED GLYCOSYLATION MODIFICATION
#1864ANTIGEN-BINDING MOLECULE SPECIFICALLY BINDING TO PSMA AND CD3, AND PHARMACEUTICAL USE THEREOF
#1865IMMUNOREACTIVE MOLECULES AND USES THEREOF
#1866TRISPECIFIC ANTIBODY TARGETING CD79b, CD20, AND CD3
#1867ANTIBODY VARIANTS AND USES THEREOF
#1868BISPECIFIC PD-L1x4-1BB ANTIBODIES AND METHODS OF USE THEREOF
#1869TNFR2 BINDING MOLECULE AND USE THEREOF
#1870ANTI-TNFR2 SINGLE DOMAIN ANTIBODY, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#1871ANTIBODY MOLECULES TO APRIL AND USES THEREOF
#1872ANTIBODY-CYTOKINE FUSION PROTEINS AND APPLICATIONS THEREOF
#1873LEPTIN ANTIBODIES AND METHOD OF REDUCING LEPTIN
#1874ANTI-IL-1-BETA ANTIBODIES
#1875Gout flare prevention methods using IL-1BETA blockers
#1876STEM CELL FACTOR INHIBITOR
#1877INTERLEUKIN 5 BINDING PROTEIN DOSAGE REGIMEN FOR USE IN TREATING POLYANGIITIS, HYPEREOSINOPHILIC SYNDROME, CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP), OR CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS (CRSSNP)
#1878ANTI-LCN-2 ANTIBODIES AS A TREATMENT FOR EYE DISORDERS
#1879ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF
#1880HIGH DOSE TREATMENTS FOR ALZHEIMER'S DISEASE
#1881VHH BASED BINDING ANTIBODIES FOR ANTHRAX AND BOTULINUM TOXINS AND METHODS OF MAKING AND USING THEREFOR
#1882C-BASED SINGLE DOMAIN ANTIBODY FOR NEUTRALIZING RESPIRATORY SYNCYTIAL VIRUS AND APPLICATION THEREOF
#1883NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO
#1884LAIR-2 Compositions and Methods
#1885METHODS FOR TREATMENT USING ANTI-ALPHA4BETA7 ANTIBODY
#1886Formulations Comprising a SADA Complex
#1887Pharmaceutical Composition Comprising Salmonella Strain and Immune Checkpoint Inhibitor as Active Ingredient for Prevention or Treatment of Cancer
#1888COMBINATION THERAPY FOR TREATMENT OF CANCER
#1889Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors
#1890LIGAND-BINDING MOLECULE HAVING ADJUSTABLE LIGAND BINDING ACTIVITY
#1891METHODS OF EFFECTING A HEMODYNAMIC CHANGE BY ADMINISTERING AN ANTI-NPR1 ANTIBODY
#1892USE OF ALPHA-ENOLASE ANTAGONIST FOR TREATING ANGIOGENESIS-RELATED DISEASES
#1893METHOD FOR PREVENTING AND/OR TREATING THROMBOEMBOLIC DISEASES
#1894ANTI-GLYCAN ANTIBODIES AND USES THEREOF
#1895ANTI-CD40 ANTIBODIES AND USES THEREOF
#1896COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES
#1897CCR8 ANTIGEN BINDING UNIT AND USES THEREOF
#1898TREATMENT OF A DEMYELINATING DISEASE OF THE CENTRAL NERVOUS SYSTEM (CNS) WITH SATRALIZUMAB
#1899REGULATING T CELL IMMUNE RESPONSE THROUGH IGF-I RECEPTOR (IGF-1R)
#1900FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY
#1901FCRN ANTAGONISTS FOR TREATMENT OF IGG-RELATED DISEASES AND DISORDERS
#1902Dosage Regimens For Anti-Pd-L1 Antibodies And Uses Thereof
#1903ANTI-PD-1 ANTIBODIES AND USES THEREOF
#1904USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH CHEMOTHERAPY IN TREATING ESOPHAGEAL CANCER
#1905MANABODIES TARGETING P53 TUMOR ANTIGENS AND METHODS OF USING
#1906MONOCLONAL ANTIBODIES AGAINST HUMAN TIM-3
#1907IL-21 POLYPEPTIDES AND TARGETED CONSTRUCTS
#1908PROTEINS AND USE THEREOF
#1909COMPOSITIONS FOR PREVENTING OR TREATING INFLUENZA INFECTIONS
#1910DRUG CONJUGATES OF cMET MONOCLONAL BINDING AGENTS, AND USES THEREOF
#1911USE OF SEMAPHORIN-4D ANTIBODIES IN COMBINATION WITH AN IMMUNE MODULATING THERAPY TO INHIBIT TUMOR GROWTH AND METASTASIS
#1912TREATMENT OF ASTHMA WITH ANTI-TSL P ANTIBODY
#1913GLUCOCORTICOID RECEPTOR BLOCKADE WITH MIFEPRISTONE TO SENSITIZE PANCREATIC CANCER TO IMMUNOTHERAPY
#1914PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
#1915THERAPEUTIC REGIMENS FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
#1916METHODS OF TREATING CHRONIC SPONTANEOUS URTICARIA USING LIGELIZUMAB
#1917MINI BODIES AS VACCINES FOR HIV
#1918ANTIGEN-BINDING PROTEINS TARGETING MELANOMA DIFFERENTIATION ANTIGENS AND USES THEREOF
#1919ADENOVIRUS ARMED WITH BISPECIFIC T CELL ACTIVATOR
#1920ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
#1921IDENTIFICATION OF PATHOGENIC IMMUNE CELL SUBSETS IN CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS
#1922TREATMENT OF CD20-POSITIVE B-CELL LYMPHOMA WITH OBINUTUZUMAB
#1923BISPECIFIC ANTIBODY AGAINST CD40 AND CLDN18.2 AND APPLICATION THEREOF
#1924ANTIBODY BINDING TO FCRN FOR TREATING AUTOIMMUNE DISEASES
#1925FELINE ANTIBODY VARIANTS
#1926A BISPECIFIC ANTI-PD-L1/VEGF ANTIBODY AND USES THEREOF
#1927COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-1 INHIBITORS
#1928Binding agents and methods of using the same
#1929Anti-SIRP-Beta1 Antibodies and Methods of Use Thereof
#1930BISPECIFIC IGG ANTIBODIES AS T CELL ENGAGERS
#1931ANTI-TGF-BETA ANTIBODIES AND THEIR USE
#1932METHODS OF TREATMENT COMPRISING ANTIBODIES BINDING TO ALPHA7BETA1 INTEGRIN ANTIBODIES
#1933Antibodies for Use as Therapeutics Against Bacterial Infections
#1934ANTI-RSV ANTIBODY AND APPLICATION THEREOF
#1935POLYPEPTIDES FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION
#1936IMMUNOGLOBULINS AND USES THEREOF
#1937METHOD FOR THE REVIVAL OF MICROGLIA AND ASTROCYTES AND APPLICATIONS THEREOF
#1938IRF-4 ENGINEERED T CELLS AND USES THEREOF IN TREATING CANCER
#1939METHOD FOR THE TREATMENT OF PROGRESSIVE CHRONIC INTERSTITIAL LUNG DISEASE
#1940ANTIBODIES THAT SPECIFICALLY BIND TO API5 PROTEIN
#1941HER3 ANTIGEN-BINDING MOLECULES
#1942TARGETING IMMUNE INFILTRATION TO THE CENTRAL NERVOUS SYSTEM (CNS)
#1943ANTI-TNFR2 ANTIBODIES AND USES THEREOF
#1944ANTI-CCR8 ANTIBODIES AND USES THEREOF
#1945ANTI-CCR8 AGENTS
#1946SMO HUMAN ANTIBODY
#1947ANTIBODIES THAT TARGET HLA-E-HOST PEPTIDE COMPLEXES AND USES THEREOF
#1948BISPECIFIC ANTIBODIES TARGETING PD1 AND VEGF
#1949IMMUNOMODULATORY TRISPECIFIC T CELL ENGAGER FUSION PROTEINS
#1950ANTI-TREM2 ANTIBODY AND USES THEREOF
#1951Bispecific Antibody against TIGIT and PD-L1, and Pharmaceutical Composition Thereof and Use Thereof
#1952METHODS, COMPOSITIONS, AND KITS FOR MODIFYING IMMUNE CELL ACTIVITY VIA KIR2DL5
#1953METHODS AND COMPOSITIONS FOR MODULATING CAR-T ACTIVITY
#1954RESISTIN-SPECIFIC ANTIBODY AND USE THEREOF
#1955Manufacturing Methods for Producing Anti-TNF Antibody Compositions
#1956ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND USES THEREOF
#1957VHH POLYPEPTIDES THAT BIND TO CLOSTRIDIUM DIFFICILE TOXIN B AND METHODS OF USE THEREOF
#1958APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS AND METHODS OF USE THEREOF
#1959APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS AND METHODS OF USE THEREOF
#1960ANTI-NECTIN-4-ANTIBODIES AND USES THEREOF
#1961METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY
#1962METHOD FOR TREATING AND/OR PREVENTING REGNASE-1-RELATED DISEASE
#1963TREATMENT WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH CTLA-4 AND PD-1 INHIBITORS
#1964TARGETED/IMMUNOMODULATORY FUSION PROTEINS AND METHODS FOR MAKING SAME
#1965ANTIBODIES AND METHODS OF USE
#1966TARGETING TUMOR CELLS WITH CHEMOTHERAPEUTIC AGENTS CONJUGATED TO MATRIPTASE ANTIBODIES
#1967ANTI-CANCER PEPTIDE
#1968Procoagulant Antibodies
#1969ANTIBODIES THAT RECOGNIZE RED BLOOD CELL ANTIGENS
#1970TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT
#1971METHOD OF TREATING A TUMOR EXPRESSING CARBONIC ANHYDRASE IX (G250) BY ADMINISTERING A G250-SPECIFIC CHIMERIC ANTIGEN RECEPTOR
#1972HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#1973Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD38-Positive Hematological Malignancies
#1974ANTIBODIES AGAINST CD14 AND USES THEREOF
#1975ANTI-CD39 Antibody, Preparation Method Therefor And Use Thereof
#1976ANTIBODIES SPECIFICALLY RECOGNIZING TNFR2 AND USES THEREOF
#1977ANTIBODIES SPECIFIC FOR CD70 AND THEIR USES
#1978COMBINATIONS OF ANTI-INFLAMMATORY AGENTS FOR TREATING ACUTE ORGAN FAILURE, ARDS, ORGANS FOR TRANSPLANTATION OR DISEASES CAUSED BY AN AIRWAY-TARGETING VIRUS
#1979METHODS OF TREATING CHRONIC GRAFT-VERSUS-HOST DISEASE-RELATED BRONCHIOLITIS OBLITERANS SYNDROME USING AN ANTI-COLONY STIMULATING FACTOR 1 RECEPTOR ANTIBODY
#1980Fc VARIANTS WITH ALTERED BINDING TO FcRn
#1981MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE OR CYSTEINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#1982Antibody Binding to Tie2 and Use Thereof
#1983CLEC12a Binding Polypeptides and Uses Thereof
#1984NEUTRALIZING ANTIBODIES TO THE ALPHA V BETA 8 INTEGRIN COMPLEX FOR IMMUNOTHERAPY
#1985FUSION PROTEINS OF HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN FC COMPOSITIONS WITH ENHANCED COMPLEMENT BINDING
#1986ANTI-CANINE PD-L1 ANTIBODIES
#1987ANTI-B7H3 ANTIBODY AND USE THEREOF
#1988Use of a Checkpoint Inhibitor in Combination with Ultralow Dose Whole Body Irradiation
#1989ANTI-CD3 ANTIBODIES WITH CROSS-REACTIVITY TO HUMAN AND CYNOMOLGUS PROTEINS
#1990ANTIBODIES TO RECEPTOR OF ADVANCED GLYCATION END PRODUCTS (RAGE) AND USES THEREOF
#1991METHODS TO REVERSE TREML1-INDUCED IMMUNE SUPPRESSION
#1992SIGLEC-6 ANTIBODIES, DERIVATIVE COMPOUNDS AND RELATED USES
#1993ANTIBODY AGAINST HUMAN TIGIT AND USE THEREOF
#1994CANCER SPECIFIC PLECTIN-1 SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
#1995METHODS FOR THE TREATMENT OF THYROID EYE DISEASE
#1996METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE
#1997Safe and Effective Method of Treating Lupus with Anti-IL/IL23 Antibody
#1998ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS
#1999PRODUCTS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA
#2000METHODS AND COMPOSITIONS FOR REDUCING CENTRALIZED PAIN
#2001METHODS OF USING ANTI-SCLEROSTIN ANTIBODIES IN TREATMENT OF OSTEOGENESIS IMPERFECTA
#2002NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE
#2003TREATMENT AND DIAGNOSIS OF DISEASES ASSOCIATED TO PATHOGENIC FIBROSIS
#2004ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF
#2005OPTIMIZED NUCLEIC ACID ANTIBODY CONSTRUCTS
#2006COMPOSTIONS
#2007MODIFIED MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS TARGETING SARS-COV-2
#2008METHODS AND COMPOSITIONS FOR PREVENTING INFECTION
#2009BENZODIAZEPINE DERIVATIVES AND ANTIBODY CONJUGATES THEREOF
#2010HUMANIZED ANTI-PACAP ANTIBODIES AND USES THEREOF
#2011Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
#2012DENDRITIC CELL-MIMICKING FUNCTIONAL NANOSTRUCTURE COMPRISING CONTAINING aCTLA-4 AND METHOD FOR PRODUCING THE SAME
#2013ANTIBODIES BINDING TO FIBROBLAST ACTIVATION PROTEIN ALPHA AND DEATH RECEPTOR 4
#2014BISPECIFIC ANTIBODIES
#2015BISPECIFIC ANTIBODY AND USE THEREOF
#2016Humanized complement 5A receptor 1 antibodies and methods of use thereof
#2017MULTISPECIFIC ANTIBODIES BINDING TO CD20, NKP46, CD16 AND CONJUGATED TO IL-2
#2018BISPECIFIC AND TRISPECIFIC BINDING PROTEINS TO PD-L1, CD137, AND/OR TGF-BETA AND USES THEREOF
#2019ANTI-CD122 ANTIBODIES, ANTI-CD132 ANTIBODIES, AND RELATED BISPECIFIC BINDING PROTEINS
#2020INHIBITOR OF TYPE 1 INTERFERON RECEPTOR STEROID SPARING IN SYSTEMIC LUPUS ERYTHERMATOSUS PATIENTS
#2021TREATMENT OF LUPUS NEPHRITIS WITH ANTI-TYPE I INF RECEPTOR ANTIBODY ANIFROLUMAB
#2022TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOUS
#2023BISPECIFIC AGONISTIC ANTIBODIES TO ACTIVIN A RECEPTOR LIKE TYPE 1 (ALK1)
#2024PREVENTION OF POSTERIOR CAPSULAR OPACIFICATION (PCO) WITH INTEGRIN AVB8 BLOCKING ANTIBODY
#2025ACTIVATABLE BISPECIFIC ANTI-CD47 AND ANTI-PD-L1 PROTEINS AND USES THEREOF
#2026HUMANIZED MONOCLONAL ANTIBODY FOR RESTORING DYSFUNCTIONAL HUMAN T AND B CELLS AGAINST CANCER AND VIRAL INFECTION
#2027METHOD FOR INHIBITING CARDIAC FIBROBLAST TRANSDIFFERENTIATION
#2028IL-11 HUMANIZED ANTIBODY AND APPLICATION THEREOF
#2029ANTI-VEGF A AND VEGF C BISPECIFIC ANTIBODIES AND USE THEREOF
#2030METHOD OF TREATING OSTEOARTHRITIS
#2031HIV-BINDING PEPTIDES AND MEDICAL USE THEREOF
#2032A GPC3-targeting antibody-interferon a fusion protein and a use thereof
#2033COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
#2034METHODS FOR TREATMENT USING ANTI-ALPHA4BETA7 ANTIBODY
#2035COMBINATION OF A PD-1 ANTAGONIST AND A VEGF-R/FGFR/RET TYROSINE KINASE INHIBITOR FOR TREATING CANCER
#2036PROTEIN S ANTIBODIES, METHODS OF MAKING AND USES THEREOF
#2037Trispecific T cell Engagers
#2038CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF
#2039EARLY INTERVENTION METHODS TO PREVENT OR AMELIORATE TOXICITY
#2040IL-18BP ANTAGONIST ANTIBODIES AND THEIR USE IN MONOTHERAPY AND COMBINATION THERAPY IN THE TREATMENT OF CANCER
#2041TrkA ANTIBODY AND APPLICATION THEREOF
#2042ANTI-VEGFR1 ANTIBODIES AND THEIR USES
#2043COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
#2044COMPOSITIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF OBTAINING THE COMPOSITIONS THEREOF
#2045ANTI-PD-1 ANTIBODY AND USE THEREOF
#2046METHODS OF SUPPRESSING MICROGLIAL ACTIVATION
#2047CYTOTOXICITY-INDUCING THERAPEUTIC AGENT FOR USE IN TREATMENT OF CANCER
#2048ANTI-TMEFF1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
#2049MECHANICALLY INTERLOCKING COMPLEXES
#2050IL-7 Binding Proteins and Their Use in Medical Therapy
#2051Anti-IL-33 Antibodies and Uses Thereof
#2052IL-13 INHIBITORS FOR THE TREATMENT OF PRURIGO NODULARIS
#2053PAN-ELR+ CXC CHEMOKINE ANTIBODIES FOR THE TREATMENT OF HIDRADENITIS SUPPURATIVA
#2054METHODS FOR TREATING ALZHEIMER'S DISEASE
#2055ANTIBODY MOLECULES TO DENGUE VIRUS AND USES THEREOF
#2056COMBINATION THERAPIES FOR HIV INFECTIONS AND USES THEREOF
#2057NEW INTERLEUKIN-7 IMMUNOCONJUGATES
#2058Albumin Bound Macromolecule Tri-Agonist Activating GLP-1/GIP/Glucagon Receptors
#2059HUMANIZED ANTIBODIES AGAINST NECTIN-2 AND DRUG CONJUGATES THEREOF
#2060Immunoconjugates and methods
#2061Immunoconjugates and methods
#2062IMMUNOCONJUGATES AND METHODS
#2063Immunoconjugates and methods
#2064Methods for Inhibiting Fibrosis in a Subject in Need Thereof
#2065COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY
#2066ANTI-TUMOR DNA VACCINE WITH PD-1 AND LAG-3 PATHWAY BLOCKADE
#2067Albumin Bound Macromolecule Tri-Agonist Activating GLP 1/GIP/Glucagon Receptors And Methods Therefor
#2068COMBINATIONS AND USES THEREOF
#2069TARGETING IMMUNE SUPPRESSION AFTER ATR INHIBITION
#2070COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY
#2071METHODS FOR TREATING SOLID CANCER PATIENTS WITH CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
#2072MONOCLONAL ANTIBODY AND A METHOD THEREOF
#2073SINGLE-DOMAIN 4-1BB ANTIBODIES
#2074COMPOSITION FOR TREATING IL-6-RELATED DISEASES
#2075ANTIBODIES AGAINST IL-7R ALPHA SUBUNIT AND USES THEREOF
#2076ANTIBODY CONJUGATES FOR THE TREATMENT OF CANCER
#2077BISPECIFIC CD16A BINDERS
#2078PD-1/TIM-3 BINDING PROTEINS FOR TREATMENT OF NSCLC and cHL
#2079CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
#2080CD3-TARGETING T-CELL ENGAGERS WITH IMPROVED THERAPEUTIC INDEX
#2081HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AND CD3
#2082COMPOSITIONS COMPRISING ANTIGEN-BINDING MOLECULES
#2083ANTI-CD47 ANTIBODIES AND METHODS OF USE THEREOF
#2084NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#2085HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE
#2086BIOPHARMACEUTICAL COMPOSITIONS AND RELATED METHODS
#2087TREATMENT FOR RHEUMATOID ARTHRITIS
#2088Therapeutic Use of Bispecific Anti-Abeta/TfR Antibodies
#2089MONOCLONAL ANTIBODY-CONTAINING COMPOSITION FOR SUPPRESSING CLOSTRIDIUM DIFFICILE BACTERIA
#2090POLYPEPTIDES, CELLS, AND METHODS INVOLVING ENGINEERED CD16
#2091Bispecific Binding Molecule
#2092NATURAL KILLER CELLS FOR CHORDOMA THERAPY
#2093COMBINATION THERAPY FOR TREATMENT OF CORONARY ARTERY DISEASE
#2094COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE DISORDERS AND CANCER
#2095WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES
#2096Combination Treatment
#2097ANTI-TSHR MULTI-SPECIFIC ANTIBODIES AND USES THEREOF
#2098SMALL MOLECULE TRAIL GENE INDUCTION BY NORMAL AND TUMOR CELLS AS AN ANTICANCER THERAPY
#2099TLR7 AGONIST AND COMBINATIONS FOR CANCER TREATMENT
#2100GENE EXPRESSION MARKERS AND TREATMENT OF MULTIPLE SCLEROSIS